Obesity Abstracts

Contents

• SPEAKER ABSTRACTS
• • A year in review: what are the highlights?
  • • Abstract unavailable

      ob0002ou1
    • Personalised obesity management

      ob0002ou2
    • Working with commercial providers to deliver weight loss services at scale

      ob0002ou3
  • Plenary 1: Identification and treatment of eating disorders in obesity
  • • Identification and treatment of eating disorders in obesity - emotional eating

      ob0002ou4
  • Debate: There is no such thing as healthy obesity
  • • Abstract unavailable

      ob0002ou5
    • Abstract unavailable

      ob0002ou6
  • Symposium: NASH & Type 2 diabetes
  • • Prevalence and Identification of NASH in type 2 diabetes

      ob0002ou7
    • Abstract unavailable

      ob0002ou8
  • Plenary 2: Is there a future for bariatric surgery in the NHS?
  • • Is there a future for bariatric surgery in the NHS?

      ob0002ou9
• CASE DISCUSSIONS
• • Case Discussions: Complex Clinical Cases 1
  • • The prevalence and impact of obesity in adults with type 1 diabetes; a cross-sectional study

      ob0002cd1.1
    • A case of refractory euglycemic diabetic ketoacidosis post elective bariatric surgery

      ob0002cd1.2
    • The use of Somatostatin Analogue and Novel use of Freestyle Libre™ continuous blood sugar monitoring in refractory Hyperinsulinaemic Hypoglycaemia Post Bariatric Surgery

      ob0002cd1.3
    • Liraglutide downregulates the expression of miRNA-424 in patients with obesity

      ob0002cd1.4
  • Case Discussions: Complex Clinical Cases 2
  • • Obstructive sleep apnoea is highly prevalent in a bariatric surgical population

      ob0002cd2.1
    • Predictors of weight loss in Tier 3 weight management service

      ob0002cd2.2
    • Significant weight loss, co-morbidity improvement and reduced health risk-factors after treatment at a multidisciplinary weight management clinic in a university hospital in Sydney, Australia

      ob0002cd2.3
• POSTER PRESENTATIONS
• • (1)
  • • A patient with hypothalamic obesity who responded well to GLP-1 agonist therapy and thereafter mini-gastric bypass surgery

      ob0002p1
    • Exploring the effects of a novel anti-diabetes compound on adipose tissue

      ob0002p2
    • The Aneurin Bevan University Health Board (ABUHB) level 3 multidisciplinary (MDT) service: description of age, demographic and anthropometric characteristics and 1-year and 2-year weight changes

      ob0002p3
    • Obesity and hypertension among civil servants in a typical Nigerian public service

      ob0002p4
    • Prevalence and determinants of metabolic health and different body composition phenotypes in a Maltese cohort

      ob0002p5
    • Anthropometric measurements and prevalence of obesity-related diseases: a cross-sectional study of overweight and obese patients in a novel multi-disciplinary weight management program

      ob0002p6
    • A case report highlighting the potential for delayed diagnosis of colorectal cancer after obesity surgery

      ob0002p7
    • Proglucagon peptide secretion post Roux-en-Y gastric bypass: one year prospective study

      ob0002p8